A Phase 1 study of JNJ-87704916, a tumor-targeting virus, injected into tumor for advanced cancer

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-506495-27-00

Acronym

87704916LUC1001

Enrollment

Registered

2024-03-25

Start date

2024-06-18

Completion date

Unknown

Last updated

2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced solid tumors

None listed

Sex/Gender

All

Age

18 Years to No maximum

France, Spain

None listed

Source: EU CTIS · Data processed: Feb 4, 2026